{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:38:05Z","timestamp":1784774285031,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13054-018-2239-y","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T08:40:04Z","timestamp":1542789604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Risk of sepsis in patients with primary aldosteronism"],"prefix":"10.1186","volume":"22","author":[{"name":"TAIPAI Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Kai","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likwang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Shuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-How","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan-Dun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"issue":"3","key":"2239_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89(3):1045\u201350.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9628","key":"2239_CR2","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","volume":"371","author":"S Douma","year":"2008","unstructured":"Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;371(9628):1921\u20136.","journal-title":"Lancet"},{"issue":"3","key":"2239_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tem.2005.02.010","volume":"16","author":"G Rossi","year":"2005","unstructured":"Rossi G, Boscaro M, Ronconi V, Funder JW. Aldosterone as a cardiovascular risk factor. Trends Endocrinol Metab. 2005;16(3):104\u20137.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"2239_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00701.x","volume":"66","author":"NK Hollenberg","year":"2004","unstructured":"Hollenberg NK. Aldosterone in the development and progression of renal injury. Kidney Int. 2004;66(1):1\u20139.","journal-title":"Kidney Int"},{"issue":"9","key":"2239_CR5","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1097\/HJH.0b013e32834a4c75","volume":"29","author":"AA Herrada","year":"2011","unstructured":"Herrada AA, Campino C, Amador CA, Michea LF, Fardella CE, Kalergis AM. Aldosterone as a modulator of immunity: implications in the organ damage. J Hypertens. 2011;29(9):1684\u201392.","journal-title":"J Hypertens"},{"issue":"2","key":"2239_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cardfail.2005.08.005","volume":"12","author":"E Kotlyar","year":"2006","unstructured":"Kotlyar E, Vita JA, Winter MR, Awtry EH, Siwik DA, Keaney JF Jr, Sawyer DB, Cupples LA, Colucci WS, Sam F. The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure. J Card Fail. 2006;12(2):122\u20137.","journal-title":"J Card Fail"},{"issue":"5","key":"2239_CR7","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","volume":"161","author":"Y Sun","year":"2002","unstructured":"Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT. Aldosterone-induced inflammation in the rat heart : role of oxidative stress. Am J Pathol. 2002;161(5):1773\u201381.","journal-title":"Am J Pathol"},{"issue":"2","key":"2239_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/(SICI)1096-8652(199910)62:2<65::AID-AJH1>3.0.CO;2-G","volume":"62","author":"S Grafte-Faure","year":"1999","unstructured":"Grafte-Faure S, Leveque C, Vasse M, Soria C, Norris V, Vannier JP. Effects of glucocorticoids and mineralocorticoids on proliferation and maturation of human peripheral blood stem cells. Am J Hematol. 1999;62(2):65\u201373.","journal-title":"Am J Hematol"},{"issue":"7","key":"2239_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1507\/endocrj.K10E-402","volume":"58","author":"K Hiraishi","year":"2011","unstructured":"Hiraishi K, Yoshimoto T, Tsuchiya K, Minami I, Doi M, Izumiyama H, Sasano H, Hirata Y. Clinicopathological features of primary aldosteronism associated with subclinical Cushing's syndrome. Endocr J. 2011;58(7):543\u201351.","journal-title":"Endocr J"},{"key":"2239_CR10","doi-asserted-by":"crossref","unstructured":"Arlt W, Lang K, Sitch AJ, Dietz AS, Rhayem Y, Bancos I, Feuchtinger A, Chortis V, Gilligan LC, Ludwig P, et al. Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism. JCI insight. 2017;2(8). [Epub ahead of print]","DOI":"10.1172\/jci.insight.93136"},{"issue":"7","key":"2239_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A. Complications of Cushing's syndrome: state of the art. Lancet Diabetes Endocrinol. 2016;4(7):611\u201329.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"2239_CR12","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jclinepi.2014.05.012","volume":"67","author":"VC Wu","year":"2014","unstructured":"Wu VC, Hu YH, Wu CH, Kao CC, Wang CY, Yang WS, Lee HH, Chang YS, Lin YH, Wang SM, et al. Administrative data on diagnosis and mineralocorticoid receptor antagonist prescription identified patients with primary aldosteronism in Taiwan. J Clin Epidemiol. 2014;67(10):1139\u201349.","journal-title":"J Clin Epidemiol"},{"key":"2239_CR13","doi-asserted-by":"publisher","first-page":"32103","DOI":"10.1038\/srep32103","volume":"6","author":"VC Wu","year":"2016","unstructured":"Wu VC, Wang SM, Chang CH, Hu YH, Lin LY, Lin YH, Chueh SC, Chen L, Wu KD. Long term outcome of aldosteronism after target treatments. Sci Rep. 2016;6:32103.","journal-title":"Sci Rep"},{"issue":"12","key":"2239_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jfma.2017.06.004","volume":"116","author":"VC Wu","year":"2017","unstructured":"Wu VC, Hu YH, Er LK, Yen RF, Chang CH, Chang YL, Lu CC, Chang CC, Lin JH, Lin YH, et al. Case detection and diagnosis of primary aldosteronism\u2014the consensus of Taiwan Society of Aldosteronism. J Formos Med Assoc. 2017;116(12):993\u20131005.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"2239_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcma.2014.11.005","volume":"78","author":"CE Chiang","year":"2015","unstructured":"Chiang CE, Wang TD, Ueng KC, Lin TH, Yeh HI, Chen CY, Wu YJ, Tsai WC, Chao TH, Chen CH, et al. 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension. J Chin Med Assoc. 2015;78(1):1\u201347.","journal-title":"J Chin Med Assoc"},{"issue":"5","key":"2239_CR16","doi-asserted-by":"publisher","first-page":"R231","DOI":"10.1186\/cc13054","volume":"17","author":"TS Lai","year":"2013","unstructured":"Lai TS, Wang CY, Pan SC, Huang TM, Lin MC, Lai CF, Wu CH, Wu VC, Chien KL. Risk of developing severe sepsis after acute kidney injury: a population-based cohort study. Crit Care. 2013;17(5):R231.","journal-title":"Crit Care"},{"issue":"2","key":"2239_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1378\/chest.09-2205","volume":"138","author":"HN Shen","year":"2010","unstructured":"Shen HN, Lu CL, Yang HH. Epidemiologic trend of severe sepsis in Taiwan from 1997 through 2006. Chest. 2010;138(2):298\u2013304.","journal-title":"Chest"},{"issue":"6","key":"2239_CR18","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992;101(6):1644\u201355.","journal-title":"Chest"},{"issue":"5","key":"2239_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/qhc.12.5.348","volume":"12","author":"N Black","year":"2003","unstructured":"Black N, Payne M. Directory of clinical databases: improving and promoting their use. Qual Saf Health Care. 2003;12(5):348\u201352.","journal-title":"Qual Saf Health Care"},{"issue":"3","key":"2239_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1681\/ASN.2013060610","volume":"25","author":"VC Wu","year":"2014","unstructured":"Wu VC, Wu CH, Huang TM, Wang CY, Lai CF, Shiao CC, Chang CH, Lin SL, Chen YY, Chen YM, et al. Long-term risk of coronary events after AKI. J Am Soc Nephrol. 2014;25(3):595\u2013605.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2239_CR21","doi-asserted-by":"publisher","first-page":"e000933","DOI":"10.1161\/JAHA.114.000933","volume":"3","author":"VC Wu","year":"2014","unstructured":"Wu VC, Wu PC, Wu CH, Huang TM, Chang CH, Tsai PR, Ko WJ, Chen L, Wang CY, Chu TS, et al. The impact of acute kidney injury on the long-term risk of stroke. J Am Heart Assoc. 2014;3(4):e000933.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2239_CR22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/jbmr.3033","volume":"32","author":"VC Wu","year":"2017","unstructured":"Wu VC, Chang CH, Wang CY, Lin YH, Kao TW, Lin PC, Chu TS, Chang YS, Chen L, Wu KD, et al. Risk of fracture in primary aldosteronism: a population-based cohort study. J Bone Miner Res. 2017;32(4):743\u201352.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2239_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1042\/CS20070123","volume":"113","author":"AM Marney","year":"2007","unstructured":"Marney AM, Brown NJ. Aldosterone and end-organ damage. Clinical Science (London, England : 1979). 2007;113(6):267\u201378.","journal-title":"Clinical Science (London, England : 1979)"},{"issue":"4","key":"2239_CR24","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1172\/JCI118867","volume":"98","author":"EL Greene","year":"1996","unstructured":"Greene EL, Kren S, Hostetter TH. Role of aldosterone in the remnant kidney model in the rat. J Clin Invest. 1996;98(4):1063\u20138.","journal-title":"J Clin Invest"},{"issue":"1","key":"2239_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1525-139X.2010.00819.x","volume":"24","author":"L Del Vecchio","year":"2011","unstructured":"Del Vecchio L, Locatelli F, Carini M. What we know about oxidative stress in patients with chronic kidney disease on dialysis\u2014clinical effects, potential treatment, and prevention. Semin Dial. 2011;24(1):56\u201364.","journal-title":"Semin Dial"},{"issue":"25","key":"2239_CR26","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1016\/j.lfs.2005.03.034","volume":"77","author":"MI Muniz-Junqueira","year":"2005","unstructured":"Muniz-Junqueira MI, Braga Lopes C, Magalhaes CA, Schleicher CC, Veiga JP. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients. Life Sci. 2005;77(25):3141\u201355.","journal-title":"Life Sci"},{"issue":"3","key":"2239_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.amjhyper.2005.08.019","volume":"19","author":"J Irita","year":"2006","unstructured":"Irita J, Okura T, Manabe S, Kurata M, Miyoshi K, Watanabe S, Fukuoka T, Higaki J. Plasma osteopontin levels are higher in patients with primary aldosteronism than in patients with essential hypertension. Am J Hypertens. 2006;19(3):293\u20137.","journal-title":"Am J Hypertens"},{"issue":"1","key":"2239_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/hr.2011.142","volume":"35","author":"R Krysiak","year":"2012","unstructured":"Krysiak R, Okopien B. The effect of treatment on monocyte and lymphocyte cytokine release in patients with aldosteronoma. Hypertens Res. 2012;35(1):123\u20135.","journal-title":"Hypertens Res"},{"issue":"3","key":"2239_CR29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.idc.2007.06.001","volume":"21","author":"GG Fareau","year":"2007","unstructured":"Fareau GG, Vassilopoulou-Sellin R. Hypercortisolemia and infection. Infect Dis Clin N Am. 2007;21(3):639\u201357 viii.","journal-title":"Infect Dis Clin N Am"},{"issue":"5","key":"2239_CR30","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1152\/ajplegacy.1967.212.5.1195","volume":"212","author":"FN White","year":"1967","unstructured":"White FN, Gold EM, Vaughn DL. Renin-aldosterone system in endotoxin shock in the dog. Am J Phys. 1967;212(5):1195\u20138.","journal-title":"Am J Phys"},{"issue":"9","key":"2239_CR31","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, Cariou A, Forceville X, Schwebel C, Martin C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9):809\u201318.","journal-title":"N Engl J Med"},{"issue":"9","key":"2239_CR32","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/BF03346533","volume":"32","author":"CA Carvajal","year":"2009","unstructured":"Carvajal CA, Herrada AA, Castillo CR, Contreras FJ, Stehr CB, Mosso LM, Kalergis AM, Fardella CE. Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha. J Endocrinol Investig. 2009;32(9):759\u201365.","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"2239_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008;168(1):80\u20135.","journal-title":"Arch Intern Med"},{"key":"2239_CR34","doi-asserted-by":"publisher","first-page":"15297","DOI":"10.1038\/srep15297","volume":"5","author":"CH Wu","year":"2015","unstructured":"Wu CH, Yang YW, Hung SC, Tsai YC, Hu YH, Lin YH, Chu TS, Wu KD, Wu VC. Effect of treatment on body fluid in patients with unilateral aldosterone producing adenoma: adrenalectomy versus spironolactone. Sci Rep. 2015;5:15297.","journal-title":"Sci Rep"},{"issue":"5","key":"2239_CR35","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","volume":"50","author":"C Catena","year":"2007","unstructured":"Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, Sechi LA. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007;50(5):911\u20138.","journal-title":"Hypertension"},{"issue":"8","key":"2239_CR36","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1097\/HJH.0000000000001361","volume":"35","author":"VC Wu","year":"2017","unstructured":"Wu VC, Chueh SJ, Chen L, Chang CH, Hu YH, Lin YH, Wu KD, Yang WS, Group TS. Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years. J Hypertens. 2017;35(8):1698\u2013708.","journal-title":"J Hypertens"},{"issue":"3","key":"2239_CR37","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1210\/jc.2009-1763","volume":"95","author":"N Sukor","year":"2010","unstructured":"Sukor N, Kogovsek C, Gordon RD, Robson D, Stowasser M. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J Clin Endocrinol Metab. 2010;95(3):1360\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2239_CR38","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1001\/archsurg.141.8.771","volume":"141","author":"WT Shen","year":"2006","unstructured":"Shen WT, Lee J, Kebebew E, Clark OH, Duh Q. Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. Arch Surg. 2006;141(8):771\u20136.","journal-title":"Arch Surg"},{"issue":"10","key":"2239_CR39","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1097\/HJH.0b013e3283635789","volume":"31","author":"K Honda","year":"2013","unstructured":"Honda K, Sone M, Tamura N, Sonoyama T, Taura D, Kojima K, Fukuda Y, Tanaka S, Yasuno S, Fujii T, et al. Adrenal reserve function after unilateral adrenalectomy in patients with primary aldosteronism. J Hypertens. 2013;31(10):2010\u20137.","journal-title":"J Hypertens"},{"issue":"2","key":"2239_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1056\/NEJMra032401","volume":"351","author":"RW Schrier","year":"2004","unstructured":"Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351(2):159\u201369.","journal-title":"N Engl J Med"},{"issue":"2","key":"2239_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/archsurg.1984.01390140011002","volume":"119","author":"RD Catalano","year":"1984","unstructured":"Catalano RD, Parameswaran V, Ramachandran J, Trunkey DD. Mechanisms of adrenocortical depression during Escherichia coli shock. Arch Surg (Chicago Ill : 1960). 1984;119(2):145\u201350.","journal-title":"Arch Surg (Chicago Ill : 1960)"},{"issue":"1","key":"2239_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","volume":"62","author":"GP Rossi","year":"2013","unstructured":"Rossi GP, Cesari M, Cuspidi C, Maiolino G, Cicala MV, Bisogni V, Mantero F, Pessina AC. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension. 2013;62(1):62\u20139.","journal-title":"Hypertension"},{"issue":"25","key":"2239_CR43","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","volume":"342","author":"J Concato","year":"2000","unstructured":"Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):1887\u201392.","journal-title":"N Engl J Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2239-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-018-2239-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2239-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T19:17:59Z","timestamp":1574277479000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-018-2239-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2239"],"URL":"https:\/\/doi.org\/10.1186\/s13054-018-2239-y","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"22 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"313"}}